A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

NCT05877859 ·Status: RECRUITING

A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer

NCT02833233 ·Status: COMPLETED ·Phase: NA

Feasibility Study on the Characterization of the Immune Profile of Young Patients After Treatment for Breast Cancer

NCT04645849 ·Status: UNKNOWN

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer

NCT04145960 ·Status: UNKNOWN

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NCT03723928 ·Status: RECRUITING ·Phase: NA

Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

NCT03719495 ·Status: COMPLETED

Discordant HER2/Neu Status of Breast Cancer.

NCT01935739 ·Status: COMPLETED

Molecular Analysis of Breast Cancer

NCT00569049 ·Status: COMPLETED

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

NCT07217990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Omission of Radiation in Patients With Her-2 Positive Breast Cancer

NCT03460067 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Clinical Study of 68Ga Labeled HER2 Affibody Analogues

NCT05411432 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer

NCT07132502 ·Status: NOT_YET_RECRUITING

Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer

NCT00084539 ·Status: COMPLETED ·Phase: PHASE2

Studying Normal Breast Tissue and Cancer Risk

NCT00341692 ·Status: COMPLETED

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

NCT00001496 ·Status: COMPLETED

The Study Will Enroll Females Who Are Coming in for Their Annual Mammogram Screening and Who Are Schedule for a Biopsy to Provide a Breath Sample Via a Mask to Evaluate if Breast Cancer Can be Detected.

NCT07266194 ·Status: NOT_YET_RECRUITING

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

NCT04273555 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

NCT06833502 ·Status: RECRUITING ·Phase: PHASE2

Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer

NCT06169007 ·Status: NOT_YET_RECRUITING

Evaluation of Prognostic Monitoring for Young Breast Cancer Patients

NCT04145986 ·Status: UNKNOWN

Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy

NCT05519397 ·Status: COMPLETED

Biomarkers in Patients With Metastatic Breast Cancer

NCT05871788 ·Status: NOT_YET_RECRUITING

Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer

NCT04661982 ·Status: ACTIVE_NOT_RECRUITING

HER2-positive Breast Cancer Registry

NCT06603597 ·Status: RECRUITING

Immune Effects in Patients Treated With Whole Breast Irradiation

NCT03567044 ·Status: UNKNOWN ·Phase: NA